HC Deb 03 April 2002 vol 382 cc1044-5W
Dr. Kumar

To ask the Secretary of State for Health what support his Department has given to Mind in the promotion, operation and analysis of its yellow card scheme. [42393]

Ms Blears

In 1997, the Medicines Control Agency (MCA) performed a detailed analysis of reports received through the Mind patient reporting scheme. Expert advice on this analysis was sought from the Committee on Safety of Medicines. No new drug safety signals were identified, although the results highlighted that patients considered that insufficient information was available to them about their medicines. There was an ongoing programme at that time to ensure that Patient Information Leaflets were authorised for all products and this programme was completed by January 1999.

In March 2001 officials at the MCA met with representatives from Mind to discuss the relaunch of their reporting scheme. MCA will be reviewing the results of Mind's analysis of the reports received through this scheme.

Forward to